The AHA, American Society of Anesthesiologists, American Society of Clinical Oncology, American Society of Health-System Pharmacists, and Institute for Safe Medication Practices today released recommendations emerging from a recent drug shortages summit, including recommendations for regulatory, legislative and other actions to address the ongoing shortages of critical medications affecting patient care. Among other actions, the recommendations include urging the Food and Drug Administration to share more information to help health care providers and manufacturers prepare for shortages. Other high-priority recommendations include conducting a Government Accountability Office study to identify new and emerging factors that contribute to shortages; developing a list of critical drugs essential for emergency response and preserving life; and offering incentives to manufacturers that create contingency production plans for pharmaceuticals on the critical drug list. The 19 recommendations were developed by participants at a recent summit examining vulnerabilities in the supply chain, U.S. dependence on foreign-sourced pharmaceutical ingredients, disaster planning and response efforts, and risk factors associated with pharmaceutical manufacturing and distribution.

Related News Articles

Headline
The Food and Drug Administration Friday released draft guidance on how drug developers can apply for the agency’s Competitive Generic Therapies designation.
Headline
The AHA today submitted to the Food and Drug Administration legislative, regulatory and best practice recommendations to address new and chronic prescription…
Headline
The National Academies of Sciences, Engineering and Medicine has released a report summarizing its Sept. 5-6 workshop on medical drug shortages during…
Headline
The Food and Drug Administration will hold a public meeting Nov. 27 to receive stakeholder input on the underlying systemic causes of drug shortages and…
Headline
Several hospitals and health systems today officially established Civica Rx – a new not-for-profit generic drug company that will help patients by addressing…
Headline
The Drug Enforcement Administration today issued its proposed 2019 aggregate production quotas for certain controlled substances, which the agency said would…